EconPapers    
Economics at your fingertips  
 

Insurance and Incentives for Medical Innovation

Garber Alan M (), Charles Jones () and Paul Romer
Additional contact information
Garber Alan M: Dept. of Veterans Affairs, Stanford University, and NBER

Forum for Health Economics & Policy, 2006, vol. 9, issue 2, 1-27

Abstract: This paper studies the interactions between health insurance and the incentives for innovation. Although we focus on pharmaceutical innovation, our discussion applies to other industries producing novel technologies for sale in markets with subsidized demand. Standard results in the growth and productivity literatures suggest that firms in many industries may possess inadequate incentives to innovate. Standard results in the health literature suggest that health insurance leads to the overutilization of health care. Our study of innovation in the pharmaceutical industry emphasizes the interaction of these incentives. Because of the large subsidies to demand from health insurance, limits on the lifetime of patents and possibly limits on monopoly pricing may be necessary to ensure that pharmaceutical companies do not possess excess incentives for innovation.

Date: 2006
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (14) Track citations by RSS feed

Downloads: (external link)
https://www.degruyter.com/view/j/fhep.2006.biomedi ... .1006.xml?format=INT (text/html)
For access to full text, subscription to the journal or payment for the individual article is required.

Related works:
Working Paper: Insurance and Incentives for Medical Innovation (2006) Downloads
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bpj:fhecpo:v:biomedical_research:y:2006:n:4

Ordering information: This journal article can be ordered from
https://www.degruyter.com/view/j/fhep

Access Statistics for this article

Forum for Health Economics & Policy is currently edited by Dana Goldman

More articles in Forum for Health Economics & Policy from De Gruyter
Bibliographic data for series maintained by Peter Golla ().

 
Page updated 2020-05-24
Handle: RePEc:bpj:fhecpo:v:biomedical_research:y:2006:n:4